Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · March 13, 2014

Early Zoledronic Acid and SREs in Prostate Cancer

Journal of Clinical Oncology

 

Additional Info

Journal of Clinical Oncology
Randomized Controlled Trial of Early Zoledronic Acid in Men With Castration-Sensitive Prostate Cancer and Bone Metastases: Results of CALGB 90202 (Alliance)
J. Clin. Oncol 2014 Mar 03;[EPub Ahead of Print], MR Smith, S Halabi, CJ Ryan, A Hussain, N Vogelzang, W Stadler, RJ Hauke, JP Monk, P Saylor, N Bhoopalam, F Saad, B Sanford, WK Kelly, M Morris, EJ Small

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Advanced Prostate Cancer Center of Excellence

Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.


Further Reading